0.29Open0.44Pre Close3 Volume136 Open Interest81.00Strike Price78.00Turnover51.47%IV1.28%PremiumDec 27, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.20Extrinsic Value100Contract SizeAmericanOptions Type0.1150Delta0.2165Gamma1068.93Leverage Ratio-0.4963Theta0.0000Rho122.91Eff Leverage0.0034Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet